Most retinoblastoma survivors have normal psychosocial functioning
the ONA take:
Most retinoblastoma survivors do not have poorer psychosocial functioning compared with people without cancer, a recent study published online ahead of print in the Journal of Clinical Oncology has shown.
Although survival rates for patients with retinoblastoma are higher than 95% in the United States, there is limited data about the long-term psychosocial outcomes of these survivors.
For the study, researchers surveyed 470 retinoblastoma survivors diagnosed between 1932 and 1994 and treated in New York. Of those, 53.6% had retinoblastoma in both eyes.
Participants completed a comprehensive questionnaire by mail or telephone to evaluate psychosocial outcomes such as psychological distress, anxiety, depression, fear of cancer recurrence, satisfaction with facial appearance, and post-traumatic stress symptoms.
Results showed that retinoblastoma survivors did not have significantly higher rates of depression, somatization, distress, or anxiety compared with noncancer controls.
Researchers also found that bilateral and unilateral retinoblastoma survivors have similar psychological symptoms.
According to the American Cancer Society, retinoblastoma is a rare disease diagnosed in only approximately 200 to 300 children each year in the United States.
Most retinoblastoma survivors do not have poorer psychosocial functioning compared with people without cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|